1 |
To share information on the current situation of access to medical abortion with an emphasis on lessons learned and challenges in expanding access. |
2 |
To examine strategies that have succeeded in improving access.
Examples include: |
• |
Appropriate introductory strategies |
• |
Advocacy for medical abortion by women's groups and others |
• |
Scientific evidence |
• |
Government action |
• |
Innovative service delivery models |
• |
Commercial interest in registering, promoting and selling drugs |
|
3 |
To examine barriers to access and how they have been addressed.
Examples include: |
• |
Restriction of provider base to ob-gyns |
• |
Obstructive regulations and bureaucratic approval processes |
• |
Higher than required dose of mifepristone approved and being used |
• |
Drugs not available or being removed from the market |
• |
Overprotective service delivery protocols |
• |
Negative provider attitudes |
|
4 |
To discuss issues causing contention within the medical abortion community including:
• |
Role of internet provision of services |
• |
Self medication |
• |
Use at different gestational ages |
|
5 |
To discuss future strategies including
• |
Organizing in the current political context |
• |
Global, regional and national networking and action |
• |
ICMA's priorities for the future |
|
| |
